{"id":"https://openalex.org/W7224739466","doi":"https://doi.org/10.1097/cce.0000000000001502","title":"Cefepime Dose Individualization in Early Sepsis: A Pragmatic Feasibility Trial Protocol.","display_name":"Cefepime Dose Individualization in Early Sepsis: A Pragmatic Feasibility Trial Protocol.","publication_year":2026,"publication_date":"2026-11-01","ids":{"openalex":"https://openalex.org/W7224739466","doi":"https://doi.org/10.1097/cce.0000000000001502","pmid":"https://pubmed.ncbi.nlm.nih.gov/42970339","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13716424"},"language":"en","primary_location":{"id":"pmid:42970339","doi":"https://doi.org/10.1097/cce.0000000000001502","is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42970339","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Critical care explorations","raw_type":"Clinical Trial Protocol"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13716424/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5086295650","display_name":"Heather Personett May","orcid":"https://orcid.org/0000-0001-5704-2867","observed_orcids":["https://orcid.org/0000-0001-5704-2867"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Heather P May","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031580643","display_name":"Andrew D. Rule","orcid":"https://orcid.org/0000-0003-0338-7784","observed_orcids":["https://orcid.org/0000-0003-0338-7784"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrew D Rule","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003304019","display_name":"Phillip J. Schulte","orcid":"https://orcid.org/0000-0001-6575-4741","observed_orcids":["https://orcid.org/0000-0001-6575-4741"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Phillip J Schulte","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022977465","display_name":"Mohamed A. Addani","orcid":"https://orcid.org/0000-0003-0813-2078","observed_orcids":["https://orcid.org/0000-0003-0813-2078"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mohamed A Addani","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082369679","display_name":"Kristin Cole","orcid":"https://orcid.org/0000-0001-5543-5341","observed_orcids":["https://orcid.org/0000-0001-5543-5341"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kristin C Cole","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160163949","display_name":"Ingrid M. Curran","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ingrid M Curran","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5116835529","display_name":"Gerald W. Flaby","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gerald W Flaby","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5129511800","display_name":"Ognjen Gajic","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ognjen Gajic","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041081700","display_name":"Paul J. Jannetto","orcid":"https://orcid.org/0000-0002-5629-439X","observed_orcids":["https://orcid.org/0000-0002-5629-439X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul J Jannetto","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160156440","display_name":"Victor Montori","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Victor Montori","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079792122","display_name":"Yewande Odeyemi","orcid":"https://orcid.org/0000-0002-4446-198X","observed_orcids":["https://orcid.org/0000-0002-4446-198X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yewande Odeyemi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113586610","display_name":"MICHAEL RANKIN","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael A Rankin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022097782","display_name":"Marc H. Scheetz","orcid":"https://orcid.org/0000-0002-1091-6130","observed_orcids":["https://orcid.org/0000-0002-1091-6130"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marc H Scheetz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160185947","display_name":"Sophia A. Steiner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sophia A Steiner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040329994","display_name":"Erin Frazee Barreto","orcid":"https://orcid.org/0000-0002-0996-1487","observed_orcids":["https://orcid.org/0000-0002-0996-1487"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Erin F Barreto","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.84038094,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"8","issue":"11","first_page":"e1502","last_page":"e1502"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10218","display_name":"Sepsis Diagnosis and Treatment","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10684","display_name":"Acute Kidney Injury Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cefepime","display_name":"cefepime","score":1.0},{"id":"https://openalex.org/keywords/sepsis","display_name":"sepsis","score":0.8149999976158142},{"id":"https://openalex.org/keywords/individualized-dosing","display_name":"individualized dosing","score":0.8500000238418579},{"id":"https://openalex.org/keywords/population-pharmacokinetic-model","display_name":"population pharmacokinetic model","score":0.6669999957084656},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.4819999933242798},{"id":"https://openalex.org/keywords/clinical-decision-support","display_name":"clinical decision support","score":0.7239999771118164},{"id":"https://openalex.org/keywords/electronic-health-records","display_name":"electronic health records","score":0.7490000128746033},{"id":"https://openalex.org/keywords/cystatin-c","display_name":"cystatin C","score":0.652999997138977},{"id":"https://openalex.org/keywords/estimated-glomerular-filtration-rate","display_name":"estimated glomerular filtration rate","score":0.8840000033378601},{"id":"https://openalex.org/keywords/beta-lactam-antibiotics","display_name":"beta-lactam antibiotics","score":0.7839999794960022},{"id":"https://openalex.org/keywords/critically-ill-adults","display_name":"critically ill adults","score":0.7329999804496765},{"id":"https://openalex.org/keywords/pharmacokinetic-simulation","display_name":"pharmacokinetic simulation","score":0.5600000023841858},{"id":"https://openalex.org/keywords/neurotoxicity","display_name":"neurotoxicity","score":0.640999972820282}],"concepts":[{"id":"https://openalex.org/C2777050379","wikidata":"https://www.wikidata.org/wiki/Q2552927","display_name":"Cefepime","level":5,"score":0.9739000201225281},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.882099986076355},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.8260999917984009},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.5745999813079834},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5005000233650208},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.453000009059906},{"id":"https://openalex.org/C2776376669","wikidata":"https://www.wikidata.org/wiki/Q5094647","display_name":"Intensive care unit","level":2,"score":0.4341000020503998},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.39800000190734863},{"id":"https://openalex.org/C2779541074","wikidata":"https://www.wikidata.org/wiki/Q185643","display_name":"Renal replacement therapy","level":2,"score":0.387800008058548},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.38350000977516174},{"id":"https://openalex.org/C2780272996","wikidata":"https://www.wikidata.org/wiki/Q1261151","display_name":"Therapeutic drug monitoring","level":3,"score":0.365200012922287},{"id":"https://openalex.org/C2780385302","wikidata":"https://www.wikidata.org/wiki/Q367158","display_name":"Protocol (science)","level":3,"score":0.36010000109672546},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3476000130176544},{"id":"https://openalex.org/C2776685102","wikidata":"https://www.wikidata.org/wiki/Q410897","display_name":"Carbapenem","level":3,"score":0.3434000015258789},{"id":"https://openalex.org/C2778384902","wikidata":"https://www.wikidata.org/wiki/Q183134","display_name":"Sepsis","level":2,"score":0.3418999910354614},{"id":"https://openalex.org/C64778159","wikidata":"https://www.wikidata.org/wiki/Q271021","display_name":"Cephalosporin","level":3,"score":0.33809998631477356},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.32829999923706055},{"id":"https://openalex.org/C2780472472","wikidata":"https://www.wikidata.org/wiki/Q424337","display_name":"Acute kidney injury","level":2,"score":0.3127000033855438},{"id":"https://openalex.org/C2987404301","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care","level":2,"score":0.3068000078201294},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.2549000084400177},{"id":"https://openalex.org/C57658597","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Pharmacovigilance","level":3,"score":0.25270000100135803},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2524000108242035}],"mesh":[{"descriptor_ui":"D000077723","descriptor_name":"Cefepime","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000077723","descriptor_name":"Cefepime","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000077723","descriptor_name":"Cefepime","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000097911","descriptor_name":"Third Generation Cephalosporins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005240","descriptor_name":"Feasibility Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016638","descriptor_name":"Critical Illness","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D018805","descriptor_name":"Sepsis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D064792","descriptor_name":"Pragmatic Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:42970339","doi":"https://doi.org/10.1097/cce.0000000000001502","is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42970339","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Critical care explorations","raw_type":"Clinical Trial Protocol"},{"id":"pmh:oai:pubmedcentral.nih.gov:13716424","doi":"https://doi.org/10.1097/cce.0000000000001502","is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13716424/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Crit Care Explor","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:13716424","doi":"https://doi.org/10.1097/cce.0000000000001502","is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13716424/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Crit Care Explor","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Study Protocol","id":"https://openalex.org/study-designs/study-protocol"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4316928180","https://openalex.org/W2089600008","https://openalex.org/W7124311611","https://openalex.org/W2120872706","https://openalex.org/W2130793449","https://openalex.org/W4408023697","https://openalex.org/W4382181847","https://openalex.org/W7160939592","https://openalex.org/W2565040967","https://openalex.org/W2730192366"],"abstract_inverted_index":{"IMPORTANCE:":[0],"Cefepime":[1],"is":[2,226],"a":[3,66,123],"core":[4],"antibiotic":[5],"in":[6,18,84,156,173,292],"sepsis":[7,298],"treatment,":[8],"yet":[9],"standard":[10],"dosing":[11,188,193,252,288],"yields":[12],"10-":[13],"to":[14,33,39,51,180,228,295],"30-fold":[15],"exposure":[16],"variability":[17],"critical":[19],"illness.":[20],"In":[21],"the":[22,57,97,157,213,250,260],"early":[23],"\"golden":[24],"hours\"":[25],"of":[26,35,59,88,125],"sepsis,":[27],"low":[28,53],"cefepime":[29,146,168,287],"levels":[30,54],"(affecting":[31],"up":[32],"70%":[34],"cases)":[36],"may":[37],"lead":[38],"organ":[40],"dysfunction":[41],"progression,":[42],"treatment":[43],"failure,":[44],"and":[45,64,73,80,90,100,208,225,265,268],"antimicrobial":[46],"resistance.":[47],"Empiric":[48],"dose":[49,172,256],"escalation":[50],"overcome":[52],"can":[55,289],"increase":[56],"risk":[58],"dose-dependent":[60],"neurotoxicity.":[61],"We":[62],"developed":[63],"qualified":[65],"population":[67],"pharmacokinetic":[68,267],"model":[69],"using":[70,274],"patient":[71],"weight":[72],"estimated":[74],"glomerular":[75],"filtration":[76],"rate":[77],"from":[78],"creatinine":[79],"cystatin":[81,217],"C":[82],"that,":[83],"simulation,":[85],"improved":[86],"attainment":[87],"effective":[89],"safe":[91],"drug":[92],"levels.":[93],"OBJECTIVES:":[94],"To":[95],"describe":[96],"Beta-Lactam":[98],"Optimization":[99],"Outcomes":[101],"Management":[102],"(BLOOM)":[103],"1":[104,170],"pragmatic":[105,115,280],"feasibility":[106,116,281],"trial.":[107],"DESIGN":[108],"SETTING":[109],"AND":[110,240],"PARTICIPANTS:":[111],"This":[112,278],"single-center,":[113],"cluster-randomized,":[114],"trial":[117,282],"(ClinicalTrials.gov:":[118],"NCT07287332)":[119],"was":[120],"approved":[121],"with":[122,254],"waiver":[124],"informed":[126],"consent.":[127],"Participants":[128],"are":[129,144,177,196],"critically":[130],"ill":[131],"adults":[132],"(age":[133],"\u2265":[134,235],"18":[135],"yr),":[136],"hospitalized":[137],"at":[138],"Mayo":[139],"Clinic":[140],"(Rochester,":[141],"MN),":[142],"who":[143,176],"receiving":[145],"for":[147,212],"suspected":[148],"or":[149,191],"documented":[150],"sepsis.":[151],"A":[152],"screening":[153],"tool":[154],"embedded":[155],"electronic":[158],"health":[159],"record":[160],"(EHR)":[161],"identifies":[162],"eligible":[163,243],"patients":[164],"newly":[165],"initiated":[166],"on":[167,221],"(\u2264":[169],"previous":[171],"48":[174],"hr)":[175],"then":[178],"randomized":[179],"care":[181],"groups":[182],"(clusters)":[183],"that":[184],"use":[185],"an":[186],"individualized":[187],"algorithm":[189,214],"(intervention)":[190],"usual-care":[192],"(control).":[194],"Exclusions":[195],"cephalosporin":[197],"allergy,":[198],"acute":[199],"kidney":[200,202],"injury,":[201],"replacement":[203],"therapy,":[204],"extracorporeal":[205],"membrane":[206],"oxygenation,":[207],"missing":[209],"inputs":[210],"required":[211],"(weight,":[215],"creatinine,":[216],"C).":[218],"Recruitment":[219],"began":[220],"January":[222,231],"15,":[223],"2026,":[224],"expected":[227],"conclude":[229],"by":[230,259],"2027":[232],"(target":[233],"enrollment,":[234],"300":[236],"patients).":[237],"INTERVENTIONS":[238],"OUTCOMES":[239],"ANALYSIS:":[241],"For":[242],"patients,":[244],"EHR-embedded":[245],"clinical":[246,261,269],"decision":[247],"support":[248],"prompts":[249],"cluster-assigned":[251],"approach,":[253],"final":[255],"decisions":[257],"made":[258],"team.":[262],"Feasibility,":[263],"fidelity,":[264],"exploratory":[266],"outcomes":[270],"will":[271,283],"be":[272,290],"assessed":[273],"mixed":[275],"methods.":[276],"CONCLUSIONS:":[277],"workflow-integrated":[279],"determine":[284],"whether":[285],"personalized":[286],"implemented":[291],"routine":[293],"practice":[294],"optimize":[296],"timely":[297],"therapy":[299],"while":[300],"maintaining":[301],"safety.":[302]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-10-31T00:00:00"}